Lin Jang-Chun, Tsai Jo-Ting, Chen Li-Jhen, Li Ming-Hsien, Liu Wei-Hsiu
Department of Radiation Oncology, Shuang Ho Hospital, Taipei Medical University, Taipei, Taiwan, ROC.
Department of Radiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan, ROC.
Oncotarget. 2017 Jun 27;8(26):42020-42029. doi: 10.18632/oncotarget.14923.
To compare treatment plans for helical tomotherapy (TOMO), volumetric modulated arc therapy (VMAT) and intensity-modulated radiotherapy (IMRT) for locally advanced rectal cancer (LARC).
This retrospective study from December 2010 to June 2013 included 20 patients with LARC who received neoadjuvant concurrent chemoradiotherapy (CCRT) with radiation doses of greater than 50.4 Gy. Dosimetric quality was evaluated based on doses to organs at risk (OARs), including small bowel, urinary bladder and bilateral femoral head, over the same coverage of the clinical target volume (CTV).
In supine comparison of IMRT with VMAT, VMAT treatment plan had a lower hot spot dose (p=0.0154) and better conformity index (CI, p=0.0036) and homogeneity index (HI, p=0.0246). Lower bladder V34.98 (p=0.0008), V40 (p=0.0058), mean dose (p<0.0001), femoral head mean dose (p=0.0089), V30 (p<0.0001), V40 (p=0.0013) and better CI (p<0.0001) and HI (p=0.0001) were observed for TOMO compared with IMRT. Patients with LARC receiving TOMO planning had lower bladder V34.98 (p=0.0021), V40 (p=0.0055), mean dose (p=0.0039), femoral head mean dose (p=0.0060), V30 (p<0.0001), and V40 (p=0.0044) and better CI (p=0.0157) and HI (p=0.0292) than VMAT. Comparing prone and supine position image planning, there were no significant differences, including in OARs in the three planning systems, except for lower bladder V34.98 (p=0.0403) in the supine position using TOMO.
Using modern radiation techniques, neither prone nor supine positions provide better values for OARs. TOMO was superior to IMRT and VMAT in sparing OARs and planning quality parameters.
比较螺旋断层放疗(TOMO)、容积调强弧形放疗(VMAT)和调强放疗(IMRT)用于局部晚期直肠癌(LARC)的治疗方案。
这项回顾性研究纳入了2010年12月至2013年6月期间接受新辅助同步放化疗(CCRT)且放疗剂量大于50.4 Gy的20例LARC患者。基于对危及器官(OARs)的剂量评估剂量学质量,这些危及器官包括小肠、膀胱和双侧股骨头,评估范围为临床靶体积(CTV)的相同覆盖范围。
在仰卧位IMRT与VMAT的比较中,VMAT治疗计划的热点剂量更低(p = 0.0154),适形指数(CI,p = 0.0036)和均匀性指数(HI,p = 0.0246)更好。与IMRT相比,TOMO的膀胱V34.98更低(p = 0.0008)、V40更低(p = 0.0058)、平均剂量更低(p < 0.0001)、股骨头平均剂量更低(p = 0.0089)、V30更低(p < 0.0001)、V40更低(p = 0.0013),且CI更好(p < 0.0001)、HI更好(p = 0.0001)。接受TOMO计划的LARC患者与VMAT相比,膀胱V34.98更低(p = 0.0021)、V40更低(p = 0.0055)、平均剂量更低(p = 0.0039)、股骨头平均剂量更低(p = 0.0060)、V30更低(p < 0.0001)、V40更低(p = 0.0044),且CI更好(p = 0.0157)、HI更好(p = 0.0292)。比较俯卧位和仰卧位图像计划,除了使用TOMO仰卧位时膀胱V34.98更低(p = 0.0403)外,在三个计划系统中的OARs方面没有显著差异。
使用现代放疗技术,俯卧位和仰卧位均未为OARs提供更好的值。在保护OARs和计划质量参数方面,TOMO优于IMRT和VMAT。